Right now, while many of us are doing our part to mitigate the spread of COVID-19, UNC-Chapel Hill’s researchers, experts, scientists and staff are fervently working to find solutions so that we can save lives, reduce suffering, and safely reopen our state, our nation and our world. Vital resources are needed now to fill the gaps in existing and evolving research opportunities for Carolina to better execute its rapid response to this global pandemic.
The breadth and depth of Carolina’s COVID-19 research is astounding but not surprising: UNC-Chapel Hill has been a leader in pandemic research for decades, from pioneering treatments for infectious diseases like HIV/AIDS to leading novel testing and development of antiviral therapies and vaccines for emerging threats like Ebola, Zika and coronavirus. Now, Carolina is tackling the COVID-19 crisis head-on through our expertise in microbiology, immunology, epidemiology, pharmacology, on-campus specialized clinical care for lungs and all other systems of the human body.